arrow
C

Carmela Gurrieri

university of padova and azienda ospedale-universita
H指数:21
被引数:2,488

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of patients with de novo and secondary acute myeloid leukaemia treated with front-line hypomethylating agents and venetoclax: A retrospective Italian study

原发性和继发性急性髓系白血病患者接受一线低甲基化药物和维奈克拉治疗后的预后:一项意大利回顾性研究

2026-05-280
OAAI
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation

真实世界研究:异基因干细胞移植的最佳CPX-351治疗时长与时机

2025-09-240
OAAI
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers
2025-01-220
OAAI
Efficacy of Venetoclax-Based Therapy Followed By Allogeneic Transplantation in Newly Diagnosed and Relapsed/Refractory AML Patients

基于Venetoclax的疗法随后进行同种异体移植在初诊和复发/难治性AML患者中的疗效

BLOOD
IF23.1
2024-11-050
PRE
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
2024-10-102
OAAI
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis
2023-12-010
OAAI
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital
2023-10-014
OAAI
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies

Tixagevimab/Cilgavimab作为血液系统恶性肿瘤患者SARS-CoV-2的暴露前预防

2023-06-228
OAAI
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
2020-10-01807
OAAI
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities

导致MECOM过度表达的复杂染色体重排在具有各种3q异常的骨髓恶性肿瘤中反复出现

2016-01-278
PREAI
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
2013-10-1252
OAAI